期刊文献+

CD4^+CD25^+调节性T细胞对内皮细胞抗原提呈功能的影响及机制 被引量:2

CD4^+CD25^+ regulatory T cells modulate antigen-presenting function of human umbilical vein endothelial cells
下载PDF
导出
摘要 目的:探讨CD4+CD25+调节性T细胞(Treg)对内皮细胞抗原提呈功能的影响及机制。方法:磁性细胞分离器(MACS)分离CD4+CD25+T细胞及CD4+CD25-T细胞。在ox-LDL作用下,HUVECs与CD4+CD25+T细胞共培养,24小时后收集HUVECs。应用流式细胞术测定HUVECs抗原提呈分子(HLA DR,CD86,CD80)的表达,Cell Counting Kit-8法(CCK-8)测定HU-VECs刺激CD4+CD25-T细胞增殖的能力,Transwell小室实验初步探讨Treg作用于HUVECs的具体机制。结果:与对照组比较,Treg可显著抑制HUVECs抗原提呈分子的表达及刺激T细胞增殖的能力。用Transwell隔离后,与or-LDL刺激组比较,HU-VECs抗原提呈分子表达及其刺激T细胞增殖的能力无明显变化。结论:Treg可显著抑制HUVECs抗原提呈能力,其作用机制可能为下调CD86的表达,且依赖细胞直接接触。 Objective:To investigate whether and how Treg affect the antigen-presenting function of HUVECs,and the mechanism of Treg in the development of atherosclerosis.Methods:Treg were isolated from human peripheral blood mononuclear cells(PBMCs) which obtained from normal volunteers by magnetic cell sorting-column and analyzed by Flow Cytometry.HUVECs were incubated alone(control) or with anti-CD3 mAbs activated Treg(CD25+) and ox-LDL.After 24 h,HUVECs were collected and the expression of HLA DR,CD80 and CD86 were measured by flow cytometry.ox-LDL treated HUVECs which were pre-cultured with different concentrations of human anti-CD3 mAbs activated Treg were used to stimulate CD4+CD25-T cells,and then the effect of HUVECs on the proliferation of CD4+CD25-T cells were detected by Cell Counting Kit-8(CCK-8).Transwell experiment was used to identify how Treg affect the antigen-presenting function of HUVECs.Results:Treg can significantly inhibit the expression of antigen presenting molecular in HUVECs as well as the effect of HUVECs on the proliferation of CD4+CD25-T cells when compared with that in control system;Mechanistic studies reveal that the expression of antigen presenting molecular in HUVECs and the effect of HUVCs on the proliferation of CD4+CD25-T cells in TW system have no difference when compared with that in no T system.Conclusion:Treg are able to modulate the antigen-presenting function of HUVECs,which is largely attributed to a down-regulated expression in CD86 in Treg-treated HUVECs and depended on cell contact.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2011年第5期391-394,403,共5页 Chinese Journal of Immunology
基金 国家自然基金资助项目(No.30670855)
关键词 CD4+CD25+调节性T细胞 人脐静脉内皮细胞系 氧化型低密度脂蛋白 抗原提呈分子 细胞增殖 TRANSWELL CD4+CD25+ Regulatory T cells Human umbilical vein endothelial cells oxidized Low-Density Lipoprotein Antigen-presenting molecules Cell proliferation
  • 相关文献

参考文献2

二级参考文献22

  • 1李大主,Sharma Ranjit,曾秋棠,田园,冯义柏,王祥,曹林生.阿托伐他汀对不稳定型心绞痛患者树突状细胞功能的影响[J].中华内科杂志,2004,43(6):429-432. 被引量:21
  • 2周军,汪建平,兰平,吴小剑,黄美近,宋新明.结肠抗原特异性T细胞克隆回输治疗大鼠溃疡性结肠炎的研究[J].中华实验外科杂志,2004,21(10):1206-1208. 被引量:14
  • 3李大主,RanjitS,吴伟,周游,曾秋棠.急性冠状动脉综合征患者树突状细胞介导的热休克蛋白60特异性细胞毒作用[J].中国循环杂志,2005,20(5):340-343. 被引量:7
  • 4Takahashi T,Tagami T,Yamazaki S,et al.Immunologic self-tolerance maintained by CD4^ + CD25 ^+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.J Exp Med,2000,192(2):303-310.
  • 5Levings MK,Sangregorio R,Roucarolo MG.Human CD4^+ CD25^+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.J Exp Med,2001,193(11):1295-1302.
  • 6Shevach EM.Certified professionals:CD4^+ CD25^+ suppressor T cells.J Exp Med,2001,193(11):F41-46.
  • 7Sakaguchi S.Policing the regulators.Nat Immumol,2001,2(4):283-284.
  • 8Shevach EM.CD4^+ CD25^+ suppressor T cells:more questions than answers.Nat Rev Immunol,2002,2(6):389-400.
  • 9Moser M.Dendritic cells in immunity and tolerance-do they display opposite functions? Immunity,2003,19(1):5-8.
  • 10Xu Q,Kiechl S,Mayr M,et al.Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis:clinical significance determined in a follow up study.Circulation,1999,100 (11):1169-1174.

共引文献14

同被引文献39

  • 1Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012 [ J ]. JAMA, 2014,311 ( 13 ) : 1308- 1316.
  • 2Vincent JL, Marshall JC, Namendys-Silva SA, et al. Assessment of the worldwide burden of critical illness: the intensive care over na- tions ( ICON ) audit [ J ]. Lancet Respir Med, 2014,2 ( 5 ) : 380- 386.
  • 3Cohen J, Vincent JL, Adbikari NK, et al. Sepsis: a roadmap for fu- ture research [ J ]. Laneet Infect Dis, 2015,15 ( 5 ) : 581-614.
  • 4Inee C, Mayeux PR, Nguyen T, et al. The endothelium in sepsis [J ]. Shoek, 2016, 45 ( 3 ) : 259-270.
  • 5Delano M J, Ward PA. Sepsis-induced immune dysfunction:can im- mune therapies reduce mortality [ J]. J Clin Invest,2016,126 ( 1 ) : 23-31.
  • 6Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans [ J]. J Exp Med, 2011,208 ( 13 ) : 2581-2590.
  • 7Opal SM ,van der Poll T. Endothelial barrier dysfunction in septic shock [J]. J Intern Meal,2015,277(3) :277-293.
  • 8Williams AE, Chambers RC. The mercurial nature of neutrophils: still an enigma in ARDS? [J].Am J Physiol Lung Cell Mol Physi- ol, 2014,306 (3) : L217-L230.
  • 9Kasten KR, Muenzer JT, Caldwell CC. Neutrophils are significant producers of IL-10 during sepsis [ J ]. Biochem Biophys Res Com- mun,2010,393 ( 1 ) : 28-31.
  • 10Saffarzadeh M, Juenemann C, Queisscr MA, et al. Neutrophil ex- tracellular traps directly induce epithelial and endothelial cell death:a predominant role of histones [ J ]. PLoS One, 2012,7 (2) : e32366.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部